1.
Kardiologiia
; 51(9): 89-91, 2011.
Article
in Russian
| MEDLINE
| ID: mdl-21943014
Subject(s)
Fatty Acids, Omega-3 , Heart Failure , Medication Therapy Management , Cardiotonic Agents/administration & dosage , Cardiotonic Agents/pharmacology , Chronic Disease , Exercise Tolerance/drug effects , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/adverse effects , Fatty Acids, Omega-3/pharmacology , Heart Failure/drug therapy , Heart Failure/mortality , Heart Failure/physiopathology , Heart Rate/drug effects , Hemodynamics/drug effects , Humans , Mortality , Myocardial Contraction/drug effects , Treatment Outcome
2.
Kardiologiia
; 17(10): 62-6, 1977 Oct.
Article
in Russian
| MEDLINE
| ID: mdl-599799
ABSTRACT
Visken (prindolol) was used in 42 patients. Its hypotensive effect was studied by the double-blind method. The hypotensive effect was encountered in 34 patients. With the administration of a placebo the arterial pressure became elevated, while after repeated prescription of the drug it again decreased significantly. Study of hemodynamics by radiocardiography in 18 patients treated with prindolol revealed no essential changes in the cardiac output, total peripheral resistance, rate of venous blood flow and volume of circulation.